
Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer
Keywords: Celecoxib; Colon cancer; MAPK; PI3K pathway; Tyrosine kinase; Ulcerative colitisDSS, dextran sulfate sodium; DMH, 1,2 dimethyl hydrazine; Erk, extracellular receptor kinase; GSK3β, glycogen synthase kinase 3β; Jak-3, Janus kinase-3; MAPK, mitogen activate